CVE:EMH - Emerald Health Therapeutics Stock Price, News, & Analysis

C$2.33
+0.05 (+2.19 %)
(As of 07/17/2019 04:00 PM ET)
Today's Range
C$2.26
Now: C$2.33
C$2.35
50-Day Range
C$2.15
MA: C$2.76
C$3.75
52-Week Range
C$2.04
Now: C$2.33
C$5.92
Volume344,744 shs
Average Volume709,614 shs
Market CapitalizationC$334.53 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis in Canada. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Victoria, Canada.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-250-8189838

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$3.71 million
Cash FlowC$0.11 per share
Book ValueC$1.19 per share

Profitability

Miscellaneous

Employees113
Market CapC$334.53 million
Next Earnings DateN/A
OptionableNot Optionable

Receive EMH News and Ratings via Email

Sign-up to receive the latest news and ratings for EMH and its competitors with MarketBeat's FREE daily newsletter.

Emerald Health Therapeutics (CVE:EMH) Frequently Asked Questions

What is Emerald Health Therapeutics' stock symbol?

Emerald Health Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EMH."

What price target have analysts set for EMH?

1 Wall Street analysts have issued 12-month price objectives for Emerald Health Therapeutics' stock. Their forecasts range from C$4.20 to C$4.20. On average, they anticipate Emerald Health Therapeutics' stock price to reach C$4.20 in the next year. This suggests a possible upside of 80.3% from the stock's current price. View Analyst Price Targets for Emerald Health Therapeutics.

What is the consensus analysts' recommendation for Emerald Health Therapeutics?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Emerald Health Therapeutics in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Emerald Health Therapeutics.

Has Emerald Health Therapeutics been receiving favorable news coverage?

Headlines about EMH stock have trended somewhat negative recently, InfoTrie Sentiment reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Emerald Health Therapeutics earned a daily sentiment score of -1.5 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Emerald Health Therapeutics.

Who are some of Emerald Health Therapeutics' key competitors?

What other stocks do shareholders of Emerald Health Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Health Therapeutics investors own include Aurora Cannabis (ACB), Aphria (APHA), Canopy Growth (WEED), Alibaba Group (BABA), Micron Technology (MU), Canopy Growth (CGC), Altria Group (MO), Emerald Health Therapeutics (EMHTF), KushCo (KSHB) and OrganiGram (OGI).

Who are Emerald Health Therapeutics' key executives?

Emerald Health Therapeutics' management team includes the folowing people:
  • Dr. Avtar S. Dhillon, Exec. Chairman, Pres & Principal Exec. Officer (Age 57)
  • Mr. Robert C. Hill C.P.A., CPA, CA, CFO & Corp. Sec.
  • Mr. Christopher W. Wagner, Consultant (Age 50)
  • Mr. Michael Bierman, VP of Operations
  • Mr. Allan Rewak, VP of Communications & Stakeholder Relations

How do I buy shares of Emerald Health Therapeutics?

Shares of EMH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Emerald Health Therapeutics' stock price today?

One share of EMH stock can currently be purchased for approximately C$2.33.

How big of a company is Emerald Health Therapeutics?

Emerald Health Therapeutics has a market capitalization of C$334.53 million and generates C$3.71 million in revenue each year. Emerald Health Therapeutics employs 113 workers across the globe.View Additional Information About Emerald Health Therapeutics.

What is Emerald Health Therapeutics' official website?

The official website for Emerald Health Therapeutics is http://www.emerald.care/.

How can I contact Emerald Health Therapeutics?

Emerald Health Therapeutics' mailing address is 4420 West Saanich Road, Rpo Royal Oak PO Box 24076, VICTORIA, BC V8Z 7E7, Canada. The company can be reached via phone at +1-250-8189838.


MarketBeat Community Rating for Emerald Health Therapeutics (CVE EMH)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  82 (Vote Outperform)
Underperform Votes:  136 (Vote Underperform)
Total Votes:  218
MarketBeat's community ratings are surveys of what our community members think about Emerald Health Therapeutics and other stocks. Vote "Outperform" if you believe EMH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EMH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/17/2019 by MarketBeat.com Staff

Featured Article: What is the Current Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel